{
  "symbol": "RVMD",
  "company_name": "Revolution Medicines Inc",
  "ir_website": "https://ir.revmed.com/",
  "structured_data": [
    {
      "section_name": "Press Releases",
      "links": [
        {
          "title": "Press Releases",
          "url": "https://ir.revmed.com/press-releases",
          "content": "[Skip to content](#lfg-main-content)\n\n# Press Releases\n\n![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/logo-outline.svg)\n\nYear All2024202320222021202020192018201720162015\n\nAll\n\nDecember 2, 2024\n\nRevolution Medicines Provides Clinical Updates from its RAS(ON) Inhibitor Portfolio\n\n[ ![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/circle-arrow.svg) ](/news-releases/news-release-details/revolution-medicines-provides-clinical-updates-its-rason)\n\nNovember 27, 2024\n\nRevolution Medicines to Host RAS(ON) Inhibitor Clinical Update Webcast on December 2, 2024\n\n[ ![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/circle-arrow.svg) ](/news-releases/news-release-details/revolution-medicines-host-rason-inhibitor-clinical-update)\n\nNovember 6, 2024\n\nRevolution Medicines Reports Third Quarter 2024 Financial Results and Update on Corporate Progress\n\n[ ![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/circle-arrow.svg) ](/news-releases/news-release-details/revolution-medicines-reports-third-quarter-2024-financial)\n\nNovember 5, 2024\n\nRevolution Medicines to Participate in Upcoming Investor Conferences\n\n[ ![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/circle-arrow.svg) ](/news-releases/news-release-details/revolution-medicines-participate-upcoming-investor-conferences-6)\n\nOctober 30, 2024\n\nRevolution Medicines to Report Financial Results for Third Quarter 2024 After Market Close on November 6, 2024\n\n[ ![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/circle-arrow.svg) ](/news-releases/news-release-details/revolution-medicines-report-financial-results-third-quarter-2024)\n\nOctober 25, 2024\n\nRevolution Medicines Presents Initial Data from RMC-9805 Monotherapy Study in Patients with Advanced Pancreatic Ductal Adenocarcinoma\n\n[ ![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/circle-arrow.svg) ](/news-releases/news-release-details/revolution-medicines-presents-initial-data-rmc-9805-monotherapy)\n\nOctober 23, 2024\n\nRevolution Medicines Presents Updated Data from RMC-6236 Monotherapy Study in Patients with Advanced Pancreatic Ductal Adenocarcinoma\n\n[ ![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/circle-arrow.svg) ](/news-releases/news-release-details/revolution-medicines-presents-updated-data-rmc-6236-monotherapy)\n\nOctober 21, 2024\n\nRevolution Medicines Announces First Patient Dosed in Phase 3 Study Evaluating RMC-6236 in Previously Treated Patients with Metastatic Pancreatic Ductal Adenocarcinoma\n\n[ ![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/circle-arrow.svg) ](/news-releases/news-release-details/revolution-medicines-announces-first-patient-dosed-phase-3-study)\n\nOctober 7, 2024\n\nRevolution Medicines to Deliver Multiple Presentations at the 2024 EORTC-NCI-AACR Symposium and Host Investor Webcast\n\n[ ![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/circle-arrow.svg) ](/news-releases/news-release-details/revolution-medicines-deliver-multiple-presentations-2024-aacr)\n\nAugust 7, 2024\n\nRevolution Medicines Reports Second Quarter 2024 Financial Results and Update on Corporate Progress\n\n[ ![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/circle-arrow.svg) ](/news-releases/news-release-details/revolution-medicines-reports-second-quarter-2024-financial)\n\nDisplaying 1 - 10 of 145 \n\n## Privacy Preference Center\n\nWhen you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer. [More information](https://www.revmed.com/privacy-policy)\n\nAllow All\n\n###  Manage Consent Preferences\n\n#### Strictly Necessary Cookies\n\nAlways Active\n\nThese cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.\n\n#### Performance Cookies\n\nPerformance Cookies\n\nThese cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.\n\n#### Functional Cookies\n\nFunctional Cookies\n\nThese cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.\n\n#### Targeting Cookies\n\nTargeting Cookies\n\nThese cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.\n\nBack Button\n\n### Performance Cookies\n\nSearch Icon\n\nFilter Icon\n\nClear\n\ncheckbox label label\n\nApply Cancel\n\nConsent Leg.Interest\n\ncheckbox label label\n\ncheckbox label label\n\ncheckbox label label\n\nDisable Cookies Confirm My Choices\n\n[](https://www.cookiepro.com/products/cookie-consent/)\n\nBy clicking “Accept All Cookies,” you agree to storing of cookies on your device to enhance site navigation, analyze usage, and assist in our marketing efforts. To learn more about how we use cookies, please see our[Privacy Policy](https://www.revmed.com/privacy-policy)\n\nCookie Settings Disable Cookies Accept All Cookies\n"
        }
      ]
    },
    {
      "section_name": "Events & Presentations",
      "links": [
        {
          "title": "Events & Presentations",
          "url": "https://ir.revmed.com/events-and-presentations",
          "content": "[Skip to content](#lfg-main-content)\n\n# Events & Presentations\n\n![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/logo-outline.svg)\n\n## Presentations\n\n[Clinical Updates on RAS(ON) Inhibitors: Monotherapy & Combinations](/static-files/34f3d4bd-7563-44a8-8eab-ea087b56919f)\n\nDecember 2, 2024\n\n[Q3 Earnings Corporate Presentation](/static-files/1980f6ca-cb1d-4568-94a7-623ccc8c0cf2)\n\nNovember 6, 2024\n\n## Upcoming Events\n\nDecember 2, 2024 8:00 AM EST\n\nRevolution Medicines, Inc. Conference Call\n\n[ ![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/circle-arrow.svg) ](/events/event-details/revolution-medicines-inc-conference-call-0)\n\n## Past Events\n\nNovember 13, 2024 5:00 PM EST\n\nUBS Global Healthcare Conference\n\n[ ![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/circle-arrow.svg) ](/events/event-details/ubs-global-healthcare-conference)\n\nNovember 12, 2024 3:00 PM EST\n\nGuggenheim Securities Healthcare Innovation Conference\n\n[ ![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/circle-arrow.svg) ](/events/event-details/guggenheim-securities-healthcare-innovation-conference)\n\nNovember 6, 2024 4:30 PM EST\n\nRevolution Medicines Q3 2024 Earnings Conference Call\n\n[ ![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/circle-arrow.svg) ](/events/event-details/revolution-medicines-q3-2024-earnings-conference-call)\n\nOctober 25, 2024 12:00 PM EDT\n\nInvestor Webcast | RMC-6236 & RMC-9805 PDAC Data Review \n\n[ ![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/circle-arrow.svg) ](/events/event-details/investor-webcast-rmc-6236-rmc-9805-pdac-data-review)\n\n## Privacy Preference Center\n\nWhen you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer. [More information](https://www.revmed.com/privacy-policy)\n\nAllow All\n\n###  Manage Consent Preferences\n\n#### Strictly Necessary Cookies\n\nAlways Active\n\nThese cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.\n\n#### Performance Cookies\n\nPerformance Cookies\n\nThese cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.\n\n#### Functional Cookies\n\nFunctional Cookies\n\nThese cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.\n\n#### Targeting Cookies\n\nTargeting Cookies\n\nThese cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.\n\nBack Button\n\n### Performance Cookies\n\nSearch Icon\n\nFilter Icon\n\nClear\n\ncheckbox label label\n\nApply Cancel\n\nConsent Leg.Interest\n\ncheckbox label label\n\ncheckbox label label\n\ncheckbox label label\n\nDisable Cookies Confirm My Choices\n\n[](https://www.cookiepro.com/products/cookie-consent/)\n\nBy clicking “Accept All Cookies,” you agree to storing of cookies on your device to enhance site navigation, analyze usage, and assist in our marketing efforts. To learn more about how we use cookies, please see our[Privacy Policy](https://www.revmed.com/privacy-policy)\n\nCookie Settings Disable Cookies Accept All Cookies\n"
        }
      ]
    },
    {
      "section_name": "SEC Filings",
      "links": [
        {
          "title": "SEC Filings",
          "url": "https://ir.revmed.com/sec-filings",
          "content": "[Skip to content](#lfg-main-content)\n\n# SEC Filings\n\n![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/logo-outline.svg)\n\nGroup 3,4,5Annual FilingsCurrent ReportsMergers & AcquisitionsOtherProxy FilingsQuarterly FilingsRegistration Statements\n\nFiling year All202420232022202120202019201820172016\n\nAll\n\n[Filing Date](?items_per_page=10&order=field_nir_sec_date_filed&sort=asc \"Sort By Filing Date\") | [Form](?items_per_page=10&order=field_nir_sec_form&sort=asc \"Sort By Form\") | [Description](?items_per_page=10&order=field_nir_sec_description&sort=asc \"Sort By Description\") | View  \n---|---|---|---  \nDecember 2, 2024 |  [8-K](/sec-filings/sec-filing/8-k/0001193125-24-268404) |  Report of unscheduled material events or corporate event |  [0001193125-24-268404.pdf](/static-files/d3c2199c-927c-45c5-af8f-337eabf4b9c7) [0001193125-24-268404.rtf](/static-files/0b56cd72-4b38-48c0-b2d1-721fa0e301bf) [0001193125-24-268404.xls](/static-files/07f11c67-39f8-4ef6-b7d8-20c14e79584b) [EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/8-k/0001193125-24-268404) [View HTML](/node/11211/html)  \nNovember 19, 2024 |  [4](/sec-filings/sec-filing/4/0001610717-24-000525) |  Statement of changes in beneficial ownership of securities |  [0001610717-24-000525.pdf](/static-files/d852d408-d5c2-4995-82ed-93e3b8f5e835) [0001610717-24-000525.rtf](/static-files/830bc55e-eb4e-4a1a-baf6-5cef718a2cb2) [0001610717-24-000525.xls](/static-files/616fe05d-c60f-4ba9-bc15-40dacbc62584) [View HTML](/node/11176/html)  \nNovember 15, 2024 |  [4](/sec-filings/sec-filing/4/0001610717-24-000522) |  Statement of changes in beneficial ownership of securities |  [0001610717-24-000522.pdf](/static-files/963a6a42-13dd-462a-b0b1-1f5bda473145) [0001610717-24-000522.rtf](/static-files/9f931a01-8e44-4e4f-aeb9-fd95498c71b6) [0001610717-24-000522.xls](/static-files/8ac71e59-3508-4ffa-ad13-11f34eca78a0) [View HTML](/node/11166/html)  \nNovember 15, 2024 |  [144](/sec-filings/sec-filing/144/0001950047-24-008666) |  Filed by \"insiders\" prior intended sale of restricted stock. Non-EDGAR filing |  [0001950047-24-008666.pdf](/static-files/18d0175b-14d6-475b-9813-e16b82ba76bf) [0001950047-24-008666.rtf](/static-files/2e4c202f-a66a-4769-a3ca-1c552faaea91) [0001950047-24-008666.xls](/static-files/2bd20679-a029-41ea-a89d-71740549b208) [View HTML](/node/11171/html)  \nNovember 13, 2024 |  [144](/sec-filings/sec-filing/144/0001950047-24-008534) |  Filed by \"insiders\" prior intended sale of restricted stock. Non-EDGAR filing |  [0001950047-24-008534.pdf](/static-files/4f7bdb46-2c01-4887-8509-3aa017019982) [0001950047-24-008534.rtf](/static-files/64f9dd1b-8a3a-48c5-98e4-8b509c9880e3) [0001950047-24-008534.xls](/static-files/dd559b25-9ab8-42c4-a1da-092d1c9c3070) [View HTML](/node/11161/html)  \nNovember 8, 2024 |  [SC 13G/A](/sec-filings/sec-filing/sc-13ga/0000902219-24-000477) |  An amendment to the SC 13G filing |  [0000902219-24-000477.pdf](/static-files/a3a4fb17-97ed-47d4-b81d-5682ad761ac4) [0000902219-24-000477.rtf](/static-files/82607adc-20c9-4f0d-b313-b0b7f1b0dfd8) [0000902219-24-000477.xls](/static-files/7a7fe10d-3657-46c9-aca6-6359e0d60bb0) [View HTML](/node/11151/html)  \nNovember 8, 2024 |  [4](/sec-filings/sec-filing/4/0001610717-24-000518) |  Statement of changes in beneficial ownership of securities |  [0001610717-24-000518.pdf](/static-files/5b013a13-d6ed-4aea-b037-8da89798ec82) [0001610717-24-000518.rtf](/static-files/74f63387-b296-4dee-913e-0a52c6858caa) [0001610717-24-000518.xls](/static-files/a4bab477-7bd9-4401-8439-7801f181c01a) [View HTML](/node/11156/html)  \nNovember 6, 2024 |  [8-K](/sec-filings/sec-filing/8-k/0000950170-24-122266) |  Report of unscheduled material events or corporate event |  [0000950170-24-122266.pdf](/static-files/3bd0ee5b-0d14-4acc-a13e-dc91046c0e62) [0000950170-24-122266.rtf](/static-files/64f6e194-6629-42af-8315-ee8cc1ebedff) [0000950170-24-122266.xls](/static-files/075f90c8-bf56-4070-88b7-e5db7f5d3c5e) [EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/8-k/0000950170-24-122266) [View HTML](/node/11136/html)  \nNovember 6, 2024 |  [10-Q](/sec-filings/sec-filing/10-q/0000950170-24-122303) |  Quarterly report which provides a continuing view of a company's financial position |  [0000950170-24-122303.pdf](/static-files/af5deeab-f91a-4d21-a647-b278e1088359) [0000950170-24-122303.rtf](/static-files/b8750ed8-5f1b-481e-9fcf-2284c35e750f) [0000950170-24-122303.xls](/static-files/6b85254b-07c8-4a9c-bc0f-4601ec8b76e9) [EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/10-q/0000950170-24-122303) [View HTML](/node/11141/html)  \nNovember 6, 2024 |  [144](/sec-filings/sec-filing/144/0001950047-24-008202) |  Filed by \"insiders\" prior intended sale of restricted stock. Non-EDGAR filing |  [0001950047-24-008202.pdf](/static-files/1acb6105-d77c-4518-a586-1f66f1426d5e) [0001950047-24-008202.rtf](/static-files/216343cd-d147-46dd-9d23-28b70607573b) [View HTML](/node/11146/html)  \n  \nData provided by [Kaleidoscope](https://www.kscope.io).\n\n## Privacy Preference Center\n\nWhen you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer. [More information](https://www.revmed.com/privacy-policy)\n\nAllow All\n\n###  Manage Consent Preferences\n\n#### Strictly Necessary Cookies\n\nAlways Active\n\nThese cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.\n\n#### Performance Cookies\n\nPerformance Cookies\n\nThese cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.\n\n#### Functional Cookies\n\nFunctional Cookies\n\nThese cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.\n\n#### Targeting Cookies\n\nTargeting Cookies\n\nThese cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.\n\nBack Button\n\n### Performance Cookies\n\nSearch Icon\n\nFilter Icon\n\nClear\n\ncheckbox label label\n\nApply Cancel\n\nConsent Leg.Interest\n\ncheckbox label label\n\ncheckbox label label\n\ncheckbox label label\n\nDisable Cookies Confirm My Choices\n\n[](https://www.cookiepro.com/products/cookie-consent/)\n\nBy clicking “Accept All Cookies,” you agree to storing of cookies on your device to enhance site navigation, analyze usage, and assist in our marketing efforts. To learn more about how we use cookies, please see our[Privacy Policy](https://www.revmed.com/privacy-policy)\n\nCookie Settings Disable Cookies Accept All Cookies\n"
        }
      ]
    },
    {
      "section_name": "Resources",
      "links": [
        {
          "title": "Investor FAQs",
          "url": "https://ir.revmed.com/resources/investor-faqs",
          "content": "[Skip to content](#lfg-main-content)\n\n# Investor FAQs\n\n![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/logo-outline.svg)\n\nWhere is Revolution Medicines' corporate headquarters? \n\n![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/down-arrow.svg)\n\nRevolution Medicines’ corporate headquarters office is located at 700 Saginaw Drive, Redwood City, CA 94063 \n\nWhen was Revolution Medicines founded? \n\n![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/down-arrow.svg)\n\nRevolution Medicines was founded in 2014. \n\nWhere is Revolution Medicines incorporated? \n\n![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/down-arrow.svg)\n\nRevolution Medicines, Inc. is incorporated under the laws of the State of Delaware. \n\nWhere is Revolution Medicines’ common stock listed and what is the ticker symbol? \n\n![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/down-arrow.svg)\n\nRevolution Medicines is listed on The Nasdaq Global Select Market under the ticker symbol RVMD. \n\nWhen did Revolution Medicines become a public company? \n\n![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/down-arrow.svg)\n\nRevolution Medicines, Inc. began trading on the Nasdaq Global Select Market on February 13, 2020. \n\nWhen does Revolution Medicines’ fiscal year end? \n\n![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/down-arrow.svg)\n\nRevolution Medicines’ fiscal year end is December 31. \n\nHow can I purchase shares of Revolution Medicines’ common stock? \n\n![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/down-arrow.svg)\n\nRevolution Medicines does not currently have a direct stock purchase plan for investors. Revolution Medicines’ stock may be purchased through a licensed securities broker. \n\nDoes Revolution Medicines pay dividends? \n\n![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/down-arrow.svg)\n\nRevolution Medicines, Inc. does not pay dividends. \n\nWho is Revolution Medicines' transfer agent and how do I contact them? \n\n![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/down-arrow.svg)\n\nAmerican Stock Transfer & Trust Company, LLC 6201 15th Avenue Brooklyn, NY 11219 \n\nWho do I contact regarding questions or changes to my stock certificates (including updating a mailing address, replacing my lost stock certificates, etc.)? \n\n![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/down-arrow.svg)\n\nFor matters related to stock certificates, please contact Revolution Medicines’ transfer agent:\n\nAmerican Stock Transfer & Trust Company, LLC 6201 15th Avenue Brooklyn, NY 11219\n\nHow can I view documents Revolution Medicines has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q? \n\n![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/down-arrow.svg)\n\nYou can visit the SEC Filings section of Revolution Medicines’ Investor Relations website or directly from the SEC’s website at <https://www.sec.gov>. \n\nHow can I sign up to receive Revolution Medicines' press releases and other company information? \n\n![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/down-arrow.svg)\n\nYou can visit the Email Alerts section of Revolution Medicines’ Investor Relations website. \n\nWho are Revolution Medicines’ independent auditors? \n\n![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/down-arrow.svg)\n\nPricewaterhouseCoopers LLP 448 Almaden Blvd, Suite #1800 San Jose, CA 95110 \n\nWho are Revolution Medicines’ outside legal counsel? \n\n![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/down-arrow.svg)\n\nLatham & Watkins LLP 140 Scott Drive Menlo Park, CA 94025 \n\nWho should I contact with additional questions? \n\n![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/down-arrow.svg)\n\nPlease email Investor Relations at IR@revmed.com for assistance with other questions \n\n## Privacy Preference Center\n\nWhen you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer. [More information](https://www.revmed.com/privacy-policy)\n\nAllow All\n\n###  Manage Consent Preferences\n\n#### Strictly Necessary Cookies\n\nAlways Active\n\nThese cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.\n\n#### Performance Cookies\n\nPerformance Cookies\n\nThese cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.\n\n#### Functional Cookies\n\nFunctional Cookies\n\nThese cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.\n\n#### Targeting Cookies\n\nTargeting Cookies\n\nThese cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.\n\nBack Button\n\n### Performance Cookies\n\nSearch Icon\n\nFilter Icon\n\nClear\n\ncheckbox label label\n\nApply Cancel\n\nConsent Leg.Interest\n\ncheckbox label label\n\ncheckbox label label\n\ncheckbox label label\n\nDisable Cookies Confirm My Choices\n\n[](https://www.cookiepro.com/products/cookie-consent/)\n\nBy clicking “Accept All Cookies,” you agree to storing of cookies on your device to enhance site navigation, analyze usage, and assist in our marketing efforts. To learn more about how we use cookies, please see our[Privacy Policy](https://www.revmed.com/privacy-policy)\n\nCookie Settings Disable Cookies Accept All Cookies\n"
        },
        {
          "title": "Email Alerts",
          "url": "https://ir.revmed.com/resources/email-alerts",
          "content": "[Skip to content](#lfg-main-content)\n\n# Email Alerts\n\n![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/logo-outline.svg)\n\nRequired fields denoted by an asterisk ().\n\nHide lower priority columns\n\nAlert type  \n---  \nQuote  \nSEC Filing  \nEvent  \nNews  \nWeekly Summary  \n  \nEmail\n\nLeave this field blank\n"
        },
        {
          "title": "Contact IR",
          "url": "https://ir.revmed.com/resources/contact-ir",
          "content": "[Skip to content](#lfg-main-content)\n\n# Contact IR\n\n![](/sites/g/files/knoqqb88216/themes/site/client_site_202/client/assets/img/logo-outline.svg)\n\nName\n\nEmail\n\nSubject\n\nComments\n\nLeave this field blank\n"
        }
      ]
    },
    {
      "section_name": "EQRx Acquisition Information",
      "links": [
        {
          "title": "IRS Form 8937 for EQRx Shareholders",
          "url": "https://ir.revmed.com/static-files/61dfe6a7-6113-47d1-992c-1316ca216654",
          "content": "\n"
        }
      ]
    }
  ]
}